Core Insights - Johnson & Johnson views the China International Import Expo as a strategic platform for promoting innovation and collaboration in the healthcare sector [1][3] Group 1: Product Innovations - Johnson & Johnson showcased over 100 innovative products across its medical technology and innovative pharmaceuticals sectors, with more than ten products making their debut [3] - The ETHICON™ 4000 3D stapler made its Asian debut, featuring a global first 3D stapling technology that enhances tissue alignment and closure integrity compared to traditional methods [3] - The CEREGLIDE™ 71 distal access catheter, also making its Asian debut, offers superior performance for establishing pathways in the neurovascular system, crucial for stroke patients [3] Group 2: Strategic Collaborations - The company introduced the first "Made in China" ultrasonic scalpel, HARMONIC® 7s, and a laparoscopic surgical robot in collaboration with local company Ruijlong Surgical [4] - Johnson & Johnson emphasizes the importance of the Import Expo in accelerating the introduction of global innovations to China and promoting "Made in China" products globally [4] Group 3: Market Engagement - The company aims to leverage the Import Expo to share innovative healthcare solutions and contribute to the development of a "Healthy China" [4] - Johnson & Johnson's innovative pharmaceuticals division highlights the Import Expo as a fast track for innovative treatment solutions to reach patients, reinforcing its commitment to the Chinese healthcare ecosystem [4]